MOTS-C
MOTS-c is supplied as a mitochondrial-derived peptide for AMPK-pathway and cellular energy-metabolism research. Supplied strictly for laboratory and educational research. Not for human or veterinary use.
Vial amount
Purchase option
Checkout includes a research-use attestation. Materials are supplied only for laboratory and educational research.
MOTS-C in research
MOTS-c is supplied as a mitochondrial-derived peptide for AMPK-pathway and cellular energy-metabolism research.
Mitochondrial, redox, and energy-pathway research for documented lab work.
Bench context
Supplied as a research-grade reference material for documented laboratory and educational research workflows.
Available amounts
Select from the stocked vial amounts for MOTS-C before adding the material to cart.
Claims discipline
No protocol instructions, no dosing, no medical advice, and no therapeutic or human-use promises.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not a drug or supplement.
As listed by the supplier in BioRegen's ordering system, shown here exactly as written for transparency. This is the vendor's own description, not independently verified, edited, or endorsed by BioRegen, and is not a BioRegen claim of any effect.
10mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Mots-c is an innovative peptide that is capturing the attention of researchers worldwide due to its unique origins and potential benefits. Derived from mitochondrial DNA, Mots-c plays a role in regulating energy metabolism, making it a valuable tool in the study of cellular function and metabolic health. Recent studies suggest Mots-c may influence how cells manage energy, which is crucial for understanding conditions related to aging and metabolic disorders.
Research into Mots-c is at the forefront of scientific inquiry, exploring its role in enhancing cellular energy production and its potential impact on longevity. By studying Mots-c, scientists aim to uncover new pathways for promoting metabolic health and improving quality of life as we age. Although still in the early stages, the research into this peptide is promising and continues to expand our knowledge of mitochondrial function and metabolic regulation.
For researchers dedicated to understanding the complexities of cellular energy and metabolism, Mots-c offers a unique opportunity to explore these areas with precision and depth. As a research tool, it stands out for its ability to provide insights into how energy is managed at the cellular level, potentially opening doors to new therapeutic approaches in the future.
The full research picture, clearly labeled
BioRegen reports the entire research landscape for this compound across four clearly separated tiers, strongest evidence first. Lower tiers, including community and anecdotal reports, are labeled as such and are not BioRegen claims.
Human clinical data is early and limited.
MOTS-c, a mitochondrial-derived peptide, has been studied in metabolic-regulation, insulin-sensitivity, and exercise-physiology models in cells and animals.
MOTS-c is discussed in longevity and performance communities. That is unverified anecdotal commentary, not controlled data, and not a BioRegen claim.
Not FDA-approved. BioRegen supplies MOTS-c reference material strictly for laboratory and educational research, not for human use.
Tiers are evidence categories, not endorsements. Clinical and preclinical entries summarize third-party published research. Community and anecdotal entries are unverified reports discussed by others, not findings and not BioRegen claims. Nothing here is medical advice, and no compound is approved for human or veterinary use except where explicitly stated under Regulatory status.
What the published research says about MOTS-C
This section reports on published research referenced in BioRegen's own research library. It is not a claim by BioRegen that the compound provides any benefit, and nothing here is medical advice.
- The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism, 2015.
- MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis. Nature Communications, 2021.